Novotech Receives “Highly Commended” in NSW Premier’s 2005

Nov 2, 2005 – Sydney, Australia — Novotech, Australia’s leading contract research organization (CRO), today announced that it has been awarded an “Highly Commended’ accolade in the prestigious NWS Premier’s 2005 Exporter of the Year Awards. Novotech CEO Alek Safarian, who attended the award’s ceremony, said he was very pleased to represent NSW and Australian [...]

Novotech CEO invited to chair clinical trials

Sept 9, 2005 – London, UK — Novotech, the largest Australian full-service contract research organization (CRO) – with offices also in the UK and USA- , has accepted the London based Pharmaceutical & Biotech Outsourcing Research & Development Expo & Conference’s [PABORD] invitation for Novotech CEO Alek Safarian to chair the Clinical Trials Session on [...]

Novotech launches innovative clinical trials risk

June 22, 2005 – Philadelphia, PA — Novotech, Australia’s largest contract research organization (CRO), today announced the launch of its Risk Sharing offering which guarantees massive savings on clinical trial costs for US firms in return for drug license rights in Australia and New Zealand. Novotech, which was this year awarded the prestigious “25 CROs [...]

Novotech, Quintiles and Pharma firms debate pros and cons

April 4, 2005 – Dallas, Texas — Novotech, Australia’s leading contract research organization (CRO), today announced that Novotech CEO Alek Safarian will debate the pros and cons of outsourcing globally at the 14th Annual Partnership with CROs and other Outsourcing Providers (April 4-6 Dallas). Other panelists include executives from pharma firms, and Quintiles Transnational. The [...]

IDC/LSI Report identifies Australia as a key region

March 17, 2005 – Sydney, Australia — Novotech, Australia’s leading contract research organization (CRO), said premier market intelligence firm Life Science Insights (LSI), part of the IDC group, had identified Australia as a prime site for CRO outsourcing following a briefing with Novotech in California recently. Alek Safarian, Novotech CEO, said he was invited to [...]

Novotech to present benefits of outsourcing clinical

March 14, 2005 – Boston, MA — Novotech, Australia’s leading contract research organization (CRO), CEO Alek Safarian has been invited to present Australia’s outstanding clinical trials capabilities at the inaugural Sachs Bloomberg CRO Partnering Forum in Boston (March 15, 2005). In the past three years, Novotech has worked with more than 15 U.S.-based pharmaceutical and [...]